Just Biotherapeutics, an integrated design company focused on technologies that will accelerate development of biotherapeutics and reduce their manufacturing cost, and Pandion Therapeutics, a biotechnology company developing novel therapeutics for the tissue-specific treatment of patients with autoimmune and inflammatory diseases and organ transplants, have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program. Just will provide ...